Showing results (311-320 of 447) with videos related to

Sort By:
Pageof 45
Immunotherapy|May 3, 2023
Health-related quality of life in patients with melanoma brain metastases treated with immunotherapyJake R Thompson, Julia Lai-Kwon, Rachael L Morton, et al.
International Journal of Molecular Sciences|January 8, 2023
Follow-Up Biomarkers in the Evolution of Prostate Cancer, Levels of S100A4 as a Detector in PlasmaMaria Jesus Alvarez-Cubero, Elena Arance, Esperanza de Santiago, et al.
Lupus Science & Medicine|May 14, 2022
Improving patient pathways for systemic lupus erythematosus: a multistakeholder pathway optimisation studyAurelien Schlencker, Laurent Messer, Marc Ardizzone, et al.
Medicina Clinica|October 17, 2024
[Cardiac amyloidosis and red flags: natural history and its impact in morbimortality]Emilio Blanco-López, Jorge Martínez-Del Río, Alba López-Calles, et al.
Cancers|May 28, 2022
MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example RegimenRichard E Kast, Alex Alfieri, Hazem I Assi, et al.
Gastroenterology Research and Practice|February 24, 2016
High Prevalence of Human Papillomavirus in Colorectal Cancer in Hispanics: A Case-Control StudyRaul D Bernabe-Dones, Maria Gonzalez-Pons, Alejandro Villar-Prados, et al.
Digestive Surgery|April 24, 2024
INDURG TRIAL Protocol: A Randomized Controlled Trial Using Indocyanine Green during Cholecystectomy in Acute CholecystitisAnna Muñoz Campaña, Pau Farre-Alins, Raquel Gracia-Roman, et al.
Circulation Research|July 9, 2021
Disrupted Resolution Mechanisms Favor Altered Phagocyte Responses in COVID-19Duco Steven Koenis, Issa Beegun, Charlotte Camille Jouvene, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitorsFunda Meric-Bernstam, Argun Akcakanat, Huiqin Chen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 9, 2026
Safety and Efficacy of Eflornithine in Patients with Gastric Precancerous Lesions: A Double-blinded, Randomized Clinical TrialDouglas R Morgan, Ricardo L Dominguez, Dalton A Norwood, et al.
Pageof 45